ZA9710877B - Anti-obesity proteins - Google Patents

Anti-obesity proteins

Info

Publication number
ZA9710877B
ZA9710877B ZA9710877A ZA9710877A ZA9710877B ZA 9710877 B ZA9710877 B ZA 9710877B ZA 9710877 A ZA9710877 A ZA 9710877A ZA 9710877 A ZA9710877 A ZA 9710877A ZA 9710877 B ZA9710877 B ZA 9710877B
Authority
ZA
South Africa
Prior art keywords
obesity proteins
obesity
proteins
Prior art date
Application number
ZA9710877A
Other languages
English (en)
Inventor
John Michael Beals
James Arthur Hoffmann
Ronald Eugene Chance
Rohn Lee Millican Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA9710877B publication Critical patent/ZA9710877B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA9710877A 1996-12-20 1997-12-03 Anti-obesity proteins ZA9710877B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3356196P 1996-12-20 1996-12-20

Publications (1)

Publication Number Publication Date
ZA9710877B true ZA9710877B (en) 1999-06-03

Family

ID=21871119

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710877A ZA9710877B (en) 1996-12-20 1997-12-03 Anti-obesity proteins

Country Status (23)

Country Link
EP (1) EP0849276A1 (cs)
JP (1) JPH10179158A (cs)
KR (1) KR19980064258A (cs)
CN (1) CN1194986A (cs)
AR (1) AR013886A1 (cs)
AU (2) AU4843297A (cs)
BR (1) BR9706358A (cs)
CA (1) CA2217698A1 (cs)
CO (1) CO4700343A1 (cs)
CZ (1) CZ407097A3 (cs)
HU (1) HUP9702500A3 (cs)
ID (1) ID19257A (cs)
IL (1) IL122569A0 (cs)
NO (1) NO975938L (cs)
NZ (1) NZ329413A (cs)
PE (1) PE47599A1 (cs)
PL (1) PL323956A1 (cs)
SG (1) SG65040A1 (cs)
SV (1) SV1997000107A (cs)
TR (1) TR199701666A3 (cs)
WO (1) WO1998028335A1 (cs)
YU (1) YU48997A (cs)
ZA (1) ZA9710877B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2338235B (en) 1997-04-15 2001-11-14 Csir Appetite suppressing plant extracts
WO1999044598A2 (en) * 1998-03-03 1999-09-10 Board Of Regents, The University Of Texas System Methods for inhibiting βcell apoptosis
GB9924484D0 (en) * 1999-10-15 1999-12-15 Isis Innovation Altered polypeptide aggregation
GB2355657B (en) 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
JP5031827B2 (ja) 2006-06-01 2012-09-26 程云 予防或いは肝損傷を治療するペプチッド
WO2025240494A1 (en) * 2024-05-13 2025-11-20 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5827734A (en) * 1995-01-20 1998-10-27 University Of Washington Materials and methods for determining ob protein in a biological sample
FI973162L (fi) * 1995-01-31 1997-09-30 Lilly Co Eli Liikalihavuutta vastustavia proteiineja
AU4862396A (en) * 1995-02-06 1996-08-27 Eli Lilly And Company Human obesity gene
AU5539596A (en) * 1995-04-06 1996-10-23 Amylin Pharmaceuticals, Inc. Anti-obesity agents
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds
CA2224867A1 (en) * 1995-06-22 1997-01-09 Eli Lilly And Company Obesity protein intermediates and their preparation and use

Also Published As

Publication number Publication date
NZ329413A (en) 1999-10-28
HUP9702500A3 (en) 1999-07-28
CN1194986A (zh) 1998-10-07
AR013886A1 (es) 2001-01-31
KR19980064258A (ko) 1998-10-07
ID19257A (id) 1998-06-28
HUP9702500A2 (hu) 1998-07-28
CZ407097A3 (cs) 1998-07-15
WO1998028335A1 (en) 1998-07-02
PL323956A1 (en) 1998-06-22
AU4843297A (en) 1998-06-25
JPH10179158A (ja) 1998-07-07
IL122569A0 (en) 1998-06-15
AU5384698A (en) 1998-07-17
PE47599A1 (es) 1999-05-14
CA2217698A1 (en) 1998-06-20
NO975938L (no) 1998-06-22
HU9702500D0 (en) 1998-03-02
YU48997A (sh) 1999-09-27
BR9706358A (pt) 1999-05-04
SV1997000107A (es) 1999-01-18
EP0849276A1 (en) 1998-06-24
NO975938D0 (no) 1997-12-17
SG65040A1 (en) 1999-05-25
TR199701666A2 (xx) 1999-10-21
CO4700343A1 (es) 1998-12-29
TR199701666A3 (tr) 1999-10-21

Similar Documents

Publication Publication Date Title
EP0810871A4 (en) ANTI-OBESITY PROTEINS
IL116970A0 (en) Anti-obesity proteins
ZA9710338B (en) Proteins
GB9609702D0 (en) Anticoagulant peptides
SG65040A1 (en) Anti-obesity proteins
ZA984322B (en) Sucrose-binding proteins
IL115317A0 (en) Proteins
GB9413316D0 (en) Novel proteins
GB9425380D0 (en) Peptides
EP1007648A4 (en) ANTI-OBESITY PROTEINS
GB9604865D0 (en) Modified proteins
GB9613705D0 (en) Novel peptides
HUP9801371A3 (en) Anti-obesity proteins
GB9607689D0 (en) Proteins
GB9707599D0 (en) Proteins
GB9624028D0 (en) Modified proteins
GB9614293D0 (en) Modified proteins
GB9611896D0 (en) Modified proteins
GB9609405D0 (en) Protein
GB9626362D0 (en) Peptides
GB9612648D0 (en) Peptides
SG55039A1 (en) Peptides
GB9606765D0 (en) Peptides
GB9608430D0 (en) Peptides
GB9605904D0 (en) Peptides